150 related articles for article (PubMed ID: 33208657)
1. Unanticipated Uterine and Cervical Malignancy in Women Undergoing Hysterectomy for Uterovaginal Prolapse.
Andiman SE; Bui AH; Hardart A; Xu X
Female Pelvic Med Reconstr Surg; 2021 Jun; 27(6):e549-e554. PubMed ID: 33208657
[TBL] [Abstract][Full Text] [Related]
2. Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse.
Frick AC; Walters MD; Larkin KS; Barber MD
Am J Obstet Gynecol; 2010 May; 202(5):507.e1-4. PubMed ID: 20452498
[TBL] [Abstract][Full Text] [Related]
3. Does prolapse equal hysterectomy? The role of uterine conservation in women with uterovaginal prolapse.
Ridgeway BM
Am J Obstet Gynecol; 2015 Dec; 213(6):802-9. PubMed ID: 26226554
[TBL] [Abstract][Full Text] [Related]
4. The Risk of Primary Uterine and Cervical Cancer After Hysteropexy.
Kurian R; Kirchhoff-Rowald A; Sahil S; Cheng AL; Wang X; Shepherd JP; Sutkin G
Female Pelvic Med Reconstr Surg; 2021 Mar; 27(3):e493-e496. PubMed ID: 33620910
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs.
Chong W; Bui AH; Menhaji K
Am J Obstet Gynecol; 2020 Aug; 223(2):268.e1-268.e26. PubMed ID: 32413430
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of the Value of Uterus instrument and visual analog scale to measure patients' valuation of their uterus.
Chang OH; Walters MD; Yao M; Lapin B
Am J Obstet Gynecol; 2022 Nov; 227(5):746.e1-746.e9. PubMed ID: 35764134
[TBL] [Abstract][Full Text] [Related]
7. Reconstructive Surgery at Hysterectomy for Patients With Uterine Prolapse and Gynecologic Malignancy.
Deshpande RR; Foy OB; Mandelbaum RS; Roman LD; Dancz CE; Wright JD; Matsuo K
Obstet Gynecol; 2023 Dec; 142(6):1487-1490. PubMed ID: 37847908
[TBL] [Abstract][Full Text] [Related]
8. Apical Suspension at the Time of Hysterectomy for Uterovaginal Prolapse: A Comparative Analysis of 2001 and 2011.
Hudson CO; Karp DR; Loucks TL; Northington GM
Female Pelvic Med Reconstr Surg; 2015; 21(6):343-7. PubMed ID: 26506163
[TBL] [Abstract][Full Text] [Related]
9. Racial and ethnic differences in reconstructive surgery for apical vaginal prolapse.
Boyd BAJ; Winkelman WD; Mishra K; Vittinghoff E; Jacoby VL
Am J Obstet Gynecol; 2021 Oct; 225(4):405.e1-405.e7. PubMed ID: 33984303
[TBL] [Abstract][Full Text] [Related]
10. Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications.
Desai VB; Wright JD; Schwartz PE; Jorgensen EM; Fan L; Litkouhi B; Lin H; Gross CP; Xu X
Obstet Gynecol; 2018 Apr; 131(4):642-651. PubMed ID: 29528920
[TBL] [Abstract][Full Text] [Related]
11. Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs.
Hemming C; Constable L; Goulao B; Kilonzo M; Boyers D; Elders A; Cooper K; Smith A; Freeman R; Breeman S; McDonald A; Hagen S; Montgomery I; Norrie J; Glazener C
Health Technol Assess; 2020 Mar; 24(13):1-220. PubMed ID: 32138809
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
[TBL] [Abstract][Full Text] [Related]
13. Uterine preservation during surgery for uterovaginal prolapse: a review.
Diwan A; Rardin CR; Kohli N
Int Urogynecol J Pelvic Floor Dysfunct; 2004; 15(4):286-92. PubMed ID: 15517676
[TBL] [Abstract][Full Text] [Related]
14. Vaginal hysterectomy for uterovaginal prolapse: what is the incidence of concurrent gynecological malignancy?
Grigoriadis T; Valla A; Zacharakis D; Protopapas A; Athanasiou S
Int Urogynecol J; 2015 Mar; 26(3):421-5. PubMed ID: 25293812
[TBL] [Abstract][Full Text] [Related]
15. Effect of Vaginal Mesh Hysteropexy vs Vaginal Hysterectomy With Uterosacral Ligament Suspension on Treatment Failure in Women With Uterovaginal Prolapse: A Randomized Clinical Trial.
Nager CW; Visco AG; Richter HE; Rardin CR; Rogers RG; Harvie HS; Zyczynski HM; Paraiso MFR; Mazloomdoost D; Grey S; Sridhar A; Wallace D;
JAMA; 2019 Sep; 322(11):1054-1065. PubMed ID: 31529008
[TBL] [Abstract][Full Text] [Related]
16. Practice patterns of general gynecologic surgeons versus gynecologic subspecialists for concomitant apical suspension during vaginal hysterectomy for uterovaginal prolapse.
Yurteri-Kaplan LA; Mete MM; St Clair C; Iglesia CB
South Med J; 2015 Jan; 108(1):17-22. PubMed ID: 25580752
[TBL] [Abstract][Full Text] [Related]
17. Uterine weight and complications after abdominal, laparoscopic, and vaginal hysterectomy.
Louie M; Strassle PD; Moulder JK; Dizon AM; Schiff LD; Carey ET
Am J Obstet Gynecol; 2018 Nov; 219(5):480.e1-480.e8. PubMed ID: 29959931
[TBL] [Abstract][Full Text] [Related]
18. Risk of malignancy in women who underwent hysterectomy for uterine prolapse.
Wan OY; Cheung RY; Chan SS; Chung TK
Aust N Z J Obstet Gynaecol; 2013 Apr; 53(2):190-6. PubMed ID: 23316927
[TBL] [Abstract][Full Text] [Related]
19. Sacrospinous ligament fixation and modified McCall culdoplasty during vaginal hysterectomy for advanced uterovaginal prolapse.
Colombo M; Milani R
Am J Obstet Gynecol; 1998 Jul; 179(1):13-20. PubMed ID: 9704759
[TBL] [Abstract][Full Text] [Related]
20. Use of prophylactic closed incision negative pressure therapy is associated with reduced surgical site infections in gynecologic oncology patients undergoing laparotomy.
Chambers LM; Morton M; Lampert E; Yao M; Debernardo R; Rose PG; Vargas R
Am J Obstet Gynecol; 2020 Nov; 223(5):731.e1-731.e9. PubMed ID: 32417358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
